고위험도 전립선암 환자의 치료
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김종욱 | - |
dc.contributor.author | 김광택 | - |
dc.contributor.author | 박재영 | - |
dc.contributor.author | 여정균 | - |
dc.date.available | 2020-02-27T06:41:56Z | - |
dc.date.created | 2020-02-12 | - |
dc.date.issued | 2019 | - |
dc.identifier.issn | 1598-8341 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/2539 | - |
dc.description.abstract | The Korean Urological Oncology Society has developed a guideline for treatment of prostate cancer by adapting various prostate cancer guidelines in a systematic manner in order to create a guideline that reflects the real practice in Korea. In this article, 5 key questions for treatment of the patients with high risk prostate cancer were suggested, and the answers were presented. Active surveillance in patients with high risk prostate cancer is not recommended. External radiotherapy combined prolonged androgen deprivation therapy are recommended rather than external radiation therapy alone for them. Extended pelvic lymphadenectomy could be considered since it provides information of accurate staging, however, it is questionable that extended pelvic lymphadenectomy increases the survival rate of high-risk prostate cancer patients. Both postoperative adjuvant radiotherapy and salvage radiotherapy can be considered when adverse pathologic features are found after radical prostatectomy. If lymph node metastasis is confirmed after radical prostatectomy with pelvic lymphadenectomy, adjuvant androgen deprivation therapy is recommended. (Korean J Urol Oncol 2019;17:34-47) | - |
dc.language | 한국어 | - |
dc.language.iso | ko | - |
dc.publisher | 대한비뇨기종양학회 | - |
dc.relation.isPartOf | 대한비뇨기종양학술지 | - |
dc.title | 고위험도 전립선암 환자의 치료 | - |
dc.title.alternative | Treatment of Patients With High Risk Prostate Cancer | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 2 | - |
dc.identifier.doi | 10.22465/kjuo.2019.17.1.34 | - |
dc.identifier.bibliographicCitation | 대한비뇨기종양학술지, v.17, no.1, pp.34 - 47 | - |
dc.identifier.kciid | ART002460924 | - |
dc.citation.endPage | 47 | - |
dc.citation.startPage | 34 | - |
dc.citation.title | 대한비뇨기종양학술지 | - |
dc.citation.volume | 17 | - |
dc.citation.number | 1 | - |
dc.contributor.affiliatedAuthor | 김광택 | - |
dc.subject.keywordAuthor | Prostatic neoplasms | - |
dc.subject.keywordAuthor | High risk | - |
dc.subject.keywordAuthor | Treatment | - |
dc.subject.keywordAuthor | Guideline | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.